Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Lacas

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|December 3, 2016
[New applications for individual participant data meta-analyses of randomized trials]Béranger Lueza, Benjamin Lacas, Jean-Pierre Pignon, et al.
BMJ Open|August 15, 2018
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experienceFlorence Fayard, Claire Petit, Benjamin Lacas, et al.
Oral Oncology|November 6, 2019
Response to R. JayarajEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2017
Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV projectPernille Lassen, Benjamin Lacas, Jean-Pierre Pignon, et al.
Oncotarget|October 21, 2016
A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerAntonin Levy, Etienne Bardet, Benjamin Lacas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2021
BEAUTY and the breast: is adjuvant chemotherapy the right time for a beauty boost? Lessons learned from a large randomized controlled trialMahasti Saghatchian, Benjamin Lacas, Cécile Charles, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Oncotarget|April 28, 2017
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patientsAngela Boros, Ludovic Lacroix, Benjamin Lacas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer groupPierre Blanchard, Jean Bourhis, Benjamin Lacas, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|December 3, 2016
[New applications for individual participant data meta-analyses of randomized trials]Béranger Lueza, Benjamin Lacas, Jean-Pierre Pignon, et al.
BMJ Open|August 15, 2018
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experienceFlorence Fayard, Claire Petit, Benjamin Lacas, et al.
Oral Oncology|November 6, 2019
Response to R. JayarajEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2017
Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV projectPernille Lassen, Benjamin Lacas, Jean-Pierre Pignon, et al.
Oncotarget|October 21, 2016
A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerAntonin Levy, Etienne Bardet, Benjamin Lacas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2021
BEAUTY and the breast: is adjuvant chemotherapy the right time for a beauty boost? Lessons learned from a large randomized controlled trialMahasti Saghatchian, Benjamin Lacas, Cécile Charles, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Oncotarget|April 28, 2017
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patientsAngela Boros, Ludovic Lacroix, Benjamin Lacas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer groupPierre Blanchard, Jean Bourhis, Benjamin Lacas, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
Pageof 3